Genmab A/S (GMAB)
32.25
-1.60
(-4.73%)
USD |
NASDAQ |
Jan 16, 16:00
32.26
0.00 (0.00%)
After-Hours: 20:00
Genmab Profit Margin (Quarterly): 39.24% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AbbVie, Inc. | 1.13% |
| Krystal Biotech, Inc. | 81.15% |
| Novo Nordisk A/S | 26.68% |
| Ascendis Pharma A/S | -28.55% |
| Evaxion AS | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 28.30% |
| Return on Assets | 22.93% |
| Return on Invested Capital | 27.54% |
| Gross Profit Margin (Quarterly) | 94.32% |
| Operating Margin (Quarterly) | 44.91% |
| Return on Net Operating Assets | 44.78% |